A Silicon Valley startup wants to make breast cancer-gene testing affordable to all Americans

April 21, 2015 4:49 PM

3 0

BRCA1 and BRCA2 are arguably the best-known human genes because their mutations are linked to an increased risk of breast and ovarian cancer. When Angelina Jolie revealed in a New York Times op-ed that she’d tested positive for the mutation and decided to undergo a double mastectomy, she also noted that: “The cost of testing for BRCA1 and BRCA2, at more than $3,000 in the United States, remains an obstacle for many women.”

Now, a Silicon Valley startup which raised $15 million in funding, wants to fix the problem and have all American women get access to a test for 19 gene mutations, including the BRCA1 and BRCA2, responsible of increasing specifically ovarian and breast cancer risk, but also linked to other cancers.

Read more

To category page